🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/07/2017 | 131,87 | 132,27 | 130,54 | 130,62 | -0,82% | 1,31% | 409.300 |
| 13/07/2017 | 130,37 | 133,00 | 129,29 | 131,70 | +1,35% | 2,85% | 662.900 |
| 12/07/2017 | 130,00 | 132,51 | 129,83 | 129,94 | +0,05% | 2,06% | 414.600 |
| 11/07/2017 | 131,48 | 131,48 | 128,27 | 129,87 | -0,82% | 2,44% | 499.500 |
| 10/07/2017 | 131,22 | 131,71 | 129,30 | 130,95 | -0,08% | 1,84% | 442.500 |
| 07/07/2017 | 132,39 | 133,00 | 130,36 | 131,05 | -0,50% | 1,99% | 637.700 |
| 06/07/2017 | 132,61 | 134,49 | 130,34 | 131,71 | -1,61% | 3,13% | 425.600 |
| 05/07/2017 | 131,12 | 134,79 | 131,12 | 133,86 | +1,47% | 2,80% | 558.900 |
| 03/07/2017 | 130,59 | 132,99 | 130,59 | 131,92 | +1,69% | 1,84% | 223.800 |
| 30/06/2017 | 131,83 | 132,03 | 128,65 | 129,73 | -1,21% | 2,56% | 452.400 |
| 29/06/2017 | 132,56 | 132,56 | 129,70 | 131,32 | -0,74% | 2,16% | 669.100 |
| 28/06/2017 | 132,01 | 132,68 | 131,07 | 132,30 | +1,04% | 1,22% | 324.200 |
| 27/06/2017 | 133,00 | 133,22 | 130,42 | 130,94 | -1,64% | 2,11% | 511.700 |
| 26/06/2017 | 131,72 | 134,16 | 131,72 | 133,12 | +1,16% | 1,85% | 482.400 |
| 23/06/2017 | 131,86 | 132,87 | 130,76 | 131,59 | -0,08% | 1,60% | 1.195.600 |
| 22/06/2017 | 131,90 | 133,45 | 130,13 | 131,70 | -0,17% | 2,52% | 413.000 |
| 21/06/2017 | 130,39 | 132,72 | 130,14 | 131,93 | +1,39% | 1,98% | 465.000 |
| 20/06/2017 | 130,12 | 132,46 | 129,94 | 130,12 | -0,36% | 1,94% | 348.000 |
| 19/06/2017 | 130,69 | 131,20 | 129,15 | 130,59 | +0,52% | 1,57% | 377.500 |
| 16/06/2017 | 130,15 | 130,36 | 128,34 | 129,92 | -0,43% | 1,55% | 578.800 |
| 15/06/2017 | 130,00 | 130,97 | 129,33 | 130,48 | +0,25% | 1,26% | 454.400 |
| 14/06/2017 | 131,22 | 131,29 | 129,29 | 130,16 | -0,75% | 1,52% | 585.900 |
| 13/06/2017 | 131,63 | 132,85 | 130,48 | 131,15 | -0,21% | 1,80% | 615.800 |
| 12/06/2017 | 130,85 | 131,48 | 130,08 | 131,42 | +0,94% | 1,07% | 666.600 |
| 09/06/2017 | 130,20 | 131,71 | 129,00 | 130,19 | +0,40% | 2,08% | 654.500 |
| 08/06/2017 | 128,36 | 131,12 | 128,23 | 129,67 | +1,15% | 2,25% | 658.100 |
| 07/06/2017 | 126,50 | 128,62 | 126,30 | 128,19 | +1,64% | 1,83% | 518.300 |
| 06/06/2017 | 125,80 | 127,32 | 125,10 | 126,12 | +0,06% | 1,76% | 355.000 |
| 05/06/2017 | 127,84 | 127,84 | 124,88 | 126,05 | -1,25% | 2,32% | 452.100 |
| 02/06/2017 | 126,29 | 128,98 | 126,28 | 127,64 | +1,37% | 2,14% | 572.700 |